Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Elsevier Acquires Aureus Sciences

Published: Thursday, January 24, 2013
Last Updated: Thursday, January 24, 2013
Bookmark and Share
Elsevier purchases content assets including databases and information tools for pharmaceutical and biotech companies.

Elsevier to expand its suite of solutions to cover the entire drug discovery and development value chain by launching new life sciences solutions.

Formed in 2002, Aureus Sciences gathers unique and high quality quantitative biological activity data for major therapeutic drug targets. This content enables researchers to identify the most promising compounds, repurpose existing compounds and identify targets with which the new compounds might interact.

"The acquisition of Aureus Sciences provides us with tremendous opportunities to generate more value for our customers," said Mark van Mierle, Managing Director Elsevier Pharmaceutical and Biotech Group. "With the combination of Aureus content assets and the content already available by Elsevier, we can create a valuable solution for those in need of improving speed and accuracy of lead-finding, decision-making and other key processes."

The acquisition enables the combination of high quality and deeply extracted content from both companies to launch new solutions for our Pharmaceutical and Biotech customers. The first evidence of this will be seen early this year with the release of a new medicinal chemistry solution.

"The integration of Aureus into Elsevier, and the consolidation of best in class content, will complement Elsevier's leadership in biomedical disciplines and strengthen our ability to offer new innovative databases to researchers in medicinal chemistry and pharmacology," said Jason Theodosiou, CEO of Aureus Sciences.  "We will see many positive synergies resulting from this combination."

The acquisition is effective immediately and financial terms of the transaction are not being disclosed.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Beating Multi-Resistant Cancer Becoming Reality
Newly-discovered selenocompounds block cancer cells’ defences against chemotherapy drugs, aiding treatments.
Thursday, July 14, 2016
Revealing the Secrets of 19th Century Fashion Industry
The dye industry of the 19th century was fast-moving and international, according to a state-of-the-art analysis of four purple dresses.
Tuesday, January 19, 2016
Biometrics Institute, Elsevier Partner for Biometrics 2014
The Biometrics Institute announce strategic partnership with Elsevier for the delivery of the Biometrics 2014 Conference & Exhibition to be held on the 21-23 October 2014 in London.
Wednesday, February 19, 2014
A Risk Gene for Cannabis Psychosis
The ability of cannabis to produce psychosis has long been an important public health concern. This concern is growing in importance as there is emerging data that cannabis exposure during adolescence may increase the risk of developing schizophrenia.
Friday, November 16, 2012
New Protocols Improve Detection of MicroRNAs for Diagnosis
MicroRNAs (miRNAs) that regulate processes including fertilization, development, and aging show promise as biomarkers of disease. They can be collected from routinely collected fluids such as blood, saliva, and urine.
Monday, December 12, 2011
Elsevier Introduces Technology Intelligence Solution for Accelerating R&D and Innovation in Europe
Elsevier’s lillumin8 combines scientific content from Elsevier and other publishers, web and patent content with intelligent web search technology.
Friday, January 23, 2009
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Researchers Develop Software That Could Facilitate Drug Development
AptaTRACE can identify aptamers, potentially speed drug advancement.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!